LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,518
تعداد مشاهده مقاله45,417,555
تعداد دریافت فایل اصل مقاله11,295,772
Khalili, Azadeh, Karim, Hosein, Bayat, Gholamreza. (1400). Theoretical Assessment of Therapeutic Effects of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors on COVID-19. سامانه مدیریت نشریات علمی, 46(4), 312-316. doi: 10.30476/ijms.2021.88753.1949
Azadeh Khalili; Hosein Karim; Gholamreza Bayat. "Theoretical Assessment of Therapeutic Effects of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors on COVID-19". سامانه مدیریت نشریات علمی, 46, 4, 1400, 312-316. doi: 10.30476/ijms.2021.88753.1949
Khalili, Azadeh, Karim, Hosein, Bayat, Gholamreza. (1400). 'Theoretical Assessment of Therapeutic Effects of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors on COVID-19', سامانه مدیریت نشریات علمی, 46(4), pp. 312-316. doi: 10.30476/ijms.2021.88753.1949
Khalili, Azadeh, Karim, Hosein, Bayat, Gholamreza. Theoretical Assessment of Therapeutic Effects of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors on COVID-19. سامانه مدیریت نشریات علمی, 1400; 46(4): 312-316. doi: 10.30476/ijms.2021.88753.1949

Theoretical Assessment of Therapeutic Effects of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors on COVID-19

Iranian Journal of Medical Sciences
مقاله 10، دوره 46، شماره 4، مهر 2021، صفحه 312-316    اصل مقاله (412.51 K)
نوع مقاله: Commentary
شناسه دیجیتال (DOI): 10.30476/ijms.2021.88753.1949
نویسندگان
Azadeh Khalili1، 2؛ Hosein Karim2؛ Gholamreza Bayat* 1، 2
1Department of Physiology-Pharmacology-Medical Physics, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
2Cardiovascular Research Center, Alborz University of Medical Sciences, Karaj, Iran
چکیده
Coronavirus disease 2019 (COVID-19) has a wide spectrum of clinical presentations and the potential to cause damage to multiple organs. Its main target organ is the respiratory system such that even a low level of pulmonary involvement can rapidly lead to acute respiratory distress syndrome in some patients. Decreased lung compliance and hypoxia might cause death due to massive alveolar damage.
کلیدواژه‌ها
ACE inhibitors؛ Angiotensin receptor antagonists؛ Covid-19
سایر فایل های مرتبط با مقاله
مراجع
  1. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420-2. doi: 10.1016/S2213-2600(20)30076-X. PubMed PMID: 32085846; PubMed Central PMCID: PMCPMC7164771.
  2. Satou R, Penrose H, Navar LG. Inflammation as a Regulator of the Renin-Angiotensin System and Blood Pressure. Curr Hypertens Rep. 2018;20:100. doi: 10.1007/s11906-018-0900-0. PubMed PMID: 30291560; PubMed Central PMCID: PMCPMC6203444.
  3. Ruiz-Ortega M, Ruperez M, Lorenzo O, Esteban V, Blanco J, Mezzano S, et al. Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int Suppl. 2002:S12-22. doi: 10.1046/j.1523-1755.62.s82.4.x. PubMed PMID: 12410849.
  4. Igase M, Kohara K, Nagai T, Miki T, Ferrario CM. Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade. Hypertens Res. 2008;31:553-9. doi: 10.1291/hypres.31.553. PubMed PMID: 18497476.
  5. Jerng JS, Hsu YC, Wu HD, Pan HZ, Wang HC, Shun CT, et al. Role of the renin-angiotensin system in ventilator-induced lung injury: an in vivo study in a rat model. Thorax. 2007;62:527-35. doi: 10.1136/thx.2006.061945. PubMed PMID: 17234658; PubMed Central PMCID: PMCPMC2117227.
  6. Wosten-van Asperen RM, Lutter R, Specht PA, Moll GN, van Woensel JB, van der Loos CM, et al. Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist. J Pathol. 2011;225:618-27. doi: 10.1002/path.2987. PubMed PMID: 22009550.
  7. Rossi GP, Sanga V, Barton M. Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients. Elife. 2020;9. doi: 10.7554/eLife.57278. PubMed PMID: 32250244; PubMed Central PMCID: PMCPMC7198232.
  8. Zhang P, Zhu L, Cai J, Lei F, Qin JJ, Xie J, et al. Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19. Circ Res. 2020;126:1671-81. doi: 10.1161/CIRCRESAHA.120.317134. PubMed PMID: 32302265; PubMed Central PMCID: PMCPMC7265882.
  9. Hippisley-Cox J, Young D, Coupland C, Channon KM, Tan PS, Harrison DA, et al. Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people. Heart. 2020;106:1503-11. doi: 10.1136/heartjnl-2020-317393. PubMed PMID: 32737124; PubMed Central PMCID: PMCPMC7509391.
  10. Fosbol EL, Butt JH, Ostergaard L, Andersson C, Selmer C, Kragholm K, et al. Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality. JAMA. 2020;324:168-77. doi: 10.1001/jama.2020.11301. PubMed PMID: 32558877; PubMed Central PMCID: PMCPMC7305566.
  11. de Abajo FJ, Rodriguez-Martin S, Lerma V, Mejia-Abril G, Aguilar M, Garcia-Luque A, et al. Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study. Lancet. 2020;395:1705-14. doi: 10.1016/S0140-6736(20)31030-8. PubMed PMID: 32416785; PubMed Central PMCID: PMCPMC7255214.
  12. Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19. N Engl J Med. 2020;382:2431-40. doi: 10.1056/NEJMoa2006923. PubMed PMID: 32356627; PubMed Central PMCID: PMCPMC7206933.
  13. Hilal-Dandan R. Renin and Angiotensin. In: Brunton LL, editor. Goodman and Gilman’s: The Pharmacological Basis of Therapeutics. 13th ed: McGraw-Hill; 2018. p. 471-88.
  14. Huang XR, Chen WY, Truong LD, Lan HY. Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease. J Am Soc Nephrol. 2003;14:1738-47. doi: 10.1097/01.asn.0000071512.93927.4e. PubMed PMID: 12819233.
  15. Chen L, Kim SM, Eisner C, Oppermann M, Huang Y, Mizel D, et al. Stimulation of renin secretion by angiotensin II blockade is Gsalpha-dependent. J Am Soc Nephrol. 2010;21:986-92. doi: 10.1681/ASN.2009030307. PubMed PMID: 20395378; PubMed Central PMCID: PMCPMC2900955.
  16. Wolf G, Ritz E. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications. Kidney Int. 2005;67:799-812. doi: 10.1111/j.1523-1755.2005.00145.x. PubMed PMID: 15698420.
  17. Sato A, Saruta T. Aldosterone breakthrough during angiotensin-converting enzyme inhibitor therapy. Am J Hypertens. 2003;16:781-8. doi: 10.1016/s0895-7061(03)00913-0. PubMed PMID: 12944039.
  18. Keidar S, Gamliel-Lazarovich A, Kaplan M, Pavlotzky E, Hamoud S, Hayek T, et al. Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients. Circ Res. 2005;97:946-53. doi: 10.1161/01.RES.0000187500.24964.7A. PubMed PMID: 16179584.
  19. Dicpinigaitis PV. Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. Chest. 2006;129:169S-73S. doi: 10.1378/chest.129.1_suppl.169S. PubMed PMID: 16428706.
  20. Broadley KJ, Blair AE, Kidd EJ, Bugert JJ, Ford WR. Bradykinin-induced lung inflammation and bronchoconstriction: role in parainfluenze-3 virus-induced inflammation and airway hyperreactivity. J Pharmacol Exp Ther. 2010;335:681-92. doi: 10.1124/jpet.110.171876. PubMed PMID: 20847038.
  21. Balla T, Baukal AJ, Eng S, Catt KJ. Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla. Mol Pharmacol. 1991;40:401-6. PubMed PMID: 1654513.
  22. Lymperopoulos A, Aukszi B. Angiotensin receptor blocker drugs and inhibition of adrenal beta-arrestin-1-dependent aldosterone production: Implications for heart failure therapy. World J Cardiol. 2017;9:200-6. doi: 10.4330/wjc.v9.i3.200. PubMed PMID: 28400916; PubMed Central PMCID: PMCPMC5368669.
  23. Dabul S, Bathgate-Siryk A, Valero TR, Jafferjee M, Sturchler E, McDonald P, et al. Suppression of adrenal betaarrestin1-dependent aldosterone production by ARBs: head-to-head comparison. Sci Rep. 2015;5:8116. doi: 10.1038/srep08116. PubMed PMID: 25631300; PubMed Central PMCID: PMCPMC4309955.
  24. Lymperopoulos A, Sturchler E, Bathgate-Siryk A, Dabul S, Garcia D, Walklett K, et al. Different potencies of angiotensin receptor blockers at suppressing adrenal beta-Arrestin1-dependent post-myocardial infarction hyperaldosteronism. J Am Coll Cardiol. 2014;64:2805-6. doi: 10.1016/j.jacc.2014.09.070. PubMed PMID: 25541135.
  25. Lai CC, Wang YH, Wang CY, Wang HC, Yu CJ, Chen L. Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:867-74. doi: 10.2147/COPD.S158634. PubMed PMID: 29563786; PubMed Central PMCID: PMCPMC5846309.
  26. de Maat S, de Mast Q, Danser AHJ, van de Veerdonk FL, Maas C. Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection. Semin Thromb Hemost. 2020;46:835-7. doi: 10.1055/s-0040-1712960. PubMed PMID: 32526773; PubMed Central PMCID: PMCPMC7645818.
آمار
تعداد مشاهده مقاله: 2,893
تعداد دریافت فایل اصل مقاله: 1,850


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب